Metoprolol recalls

The FDA has published 40 recalls involving Metoprolol since 2012. The latest was reported on 20 May 2026. Most were for potency & assay. Wockhardt Usa has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls40since 2012
Last 12 months5reported
Class I00% of total
Ongoing9latest 20 May 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 38 95%Class III 2 5%

By year

Ongoing metoprolol recalls

9 active

All metoprolol recalls, newest first

40 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 25 mg* recalledMetoprolol SuccinateAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets recalledMetoprolol SuccinateTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol SuccinateTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol SuccinateTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol SuccinateTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIMetoprolol Tartrate Tablets, USP, 50 mg recalledWestminster PharmaceuticalsNitrosamine ImpurityNationwide
DrugCLASS IIMetoprolol Tartrate Tablets, USP, 100 mg recalledWestminster PharmaceuticalsNitrosamine ImpurityNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 25 mg recalledMetoprolol SuccinateGranules PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIMetoprolol Tartrate Tablets USP, 25mg recalledMetoprolol TartrateRubicon Research PrivateForeign MaterialNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 50 mg recalledMetoprolol SuccinateCardinal HealthcareManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 50 mg recalledMetoprolol SuccinateAmerisource Health ServicesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP 50 mg recalledMetoprolol SuccinateAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP 50 mg recalledMetoprolol SuccinateAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP 25 mg recalledMetoprolol SuccinateAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 25 mg recalledMetoprolol SuccinateAscend LaboratoriesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP 50 mg recalledMetoprolol SuccinateAmerican Health PackagingPotency & AssayNationwide
DrugCLASS IIMetoprolol Tartrate Tablets, USP 25 mg recalledMetoprolol TartrateRubicon Research PrivateForeign MaterialNationwide
DrugCLASS IIMetoprolol Tartrate Tablets USP 100 mg recalled by Aurobindo Pharma USAMetoprolol TartrateAurobindo Pharma USAForeign MaterialNationwide
DrugCLASS IIMetoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg recalledMetoprolol Tartrate And HydrochlorothiazideCardinal HealthManufacturing (CGMP) DeviationsFL, GA, SC
DrugCLASS IIIMetoprolol Tartrate Injection, USP 5mg/, vials recalled by RemedyRepackRemedyRepackPotency & AssayNY
DrugCLASS IIIMetoprolol Tartrate Injection, USP, 5 mg recalled by Baxter HealthcareMetoprololBaxter HealthcareForeign MaterialNationwide
DrugCLASS IIMetoprolol Succinate Extended Release Tablets, USP 50 mg recalledTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 100 mg recalledMetoprolol SuccinateDr. Reddy's LaboratoriesOtherNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets recalled by Wockhardt UsaWockhardt UsaManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets recalled by Wockhardt UsaWockhardt UsaManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets recalled by Wockhardt UsaWockhardt UsaManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets recalled by Wockhardt UsaWockhardt UsaManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMetoprolol Succinate Extended-release Tablets, USP 50mg recalledMylan PharmaceuticalsOtherNationwide
DrugCLASS IIDr. Reddy's Metoprolol Succinate Extended Release Tablets, USP 25 mg recalledMetoprolol SuccinateDr. Reddy's LaboratoriesPotency & AssayNationwide
DrugCLASS IIMetoprolol Succinate Extended-Release Tablets, USP, 100 mg recalledWockhardt UsaPotency & AssayNationwide

Should you stop taking Metoprolol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.